Stem cell therapy: Boon or bane? A comprehensive study on the inadequacy of the DOH administrative order 2013-012 and FDA circular 2013-017, regulatory policies on the administration of stem cell products in hospitals, clinics, and laboratories

Date of Publication

2013

Document Type

Bachelor's Thesis

Degree Name

Bachelor of Science in Legal Management

Subject Categories

Law | Medical Jurisprudence

College

Ramon V. Del Rosario College of Business

Department/Unit

Commercial Law

Thesis Adviser

Edward P. Chico

Defense Panel Chair

James Keith C. Heffron

Defense Panel Member

Richard J. Netehrcott
Larry P. Ignacio

Abstract/Summary

This thesis paper entitled, Stem Cell Therapy: boon or bane? intends to provide a comprehensive study on the inadequacies of the DOH Administrative Order 2013-0012 and FDA Circular 2013-017, which are the relevant administrative orders governing the use of stem cell products in hospitals, clinics, and laboratories.

The aforementioned administrative orders will be discussed in light of the provisions provided for under the FDA Act of 2009 and the Consumer Act of the Philippines. The relevant provisions of the said statutes will be exhausted in order to establish the objectives of the paper, which are: (1) to establish the inadequacy of the DOH Administrative Order 2013-12 and FDA Circular 2013-17 and (2) to propose a bill that shall cover the inadequacies of the DOH Administrative Order and FDA Circular.

Abstract Format

html

Language

English

Format

Print

Accession Number

TU18600

Shelf Location

Archives, The Learning Commons, 12F, Henry Sy Sr. Hall

Physical Description

97 leaves, 28 cm.

Keywords

Stem cells—Transplantation--Law and legislation--Philippines

Embargo Period

4-27-2021

This document is currently not available here.

Share

COinS